Search research articles
Contact Us
Filters
Showing results (131-140 of 135) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 135 results.
Cancer Cell
|
November 7, 2025
Multimodal spatial-omics reveal co-evolution of alveolar progenitors and proinflammatory niches in progression of lung precursor lesions
Fuduan Peng, Ansam Sinjab, Yibo Dai, et al.
Genome Biology
|
November 5, 2020
Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity
Won-Chul Lee, Alexandre Reuben, Xin Hu, et al.
Nature Communications
|
February 1, 2020
Comprehensive T cell repertoire characterization of non-small cell lung cancer
Alexandre Reuben, Jiexin Zhang, Shin-Heng Chiou, et al.
Nature Medicine
|
February 19, 2021
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Tina Cascone, William N William, Annikka Weissferdt, et al.
Cancer Discovery
|
May 19, 2018
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 135) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 135 results.
Cancer Cell
|
November 7, 2025
Multimodal spatial-omics reveal co-evolution of alveolar progenitors and proinflammatory niches in progression of lung precursor lesions
Fuduan Peng, Ansam Sinjab, Yibo Dai, et al.
Genome Biology
|
November 5, 2020
Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity
Won-Chul Lee, Alexandre Reuben, Xin Hu, et al.
Nature Communications
|
February 1, 2020
Comprehensive T cell repertoire characterization of non-small cell lung cancer
Alexandre Reuben, Jiexin Zhang, Shin-Heng Chiou, et al.
Nature Medicine
|
February 19, 2021
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Tina Cascone, William N William, Annikka Weissferdt, et al.
Cancer Discovery
|
May 19, 2018
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, et al.
Page
of 14